Last reviewed · How we verify
Potassium Iodide (POTASSIUM IODIDE)
At a glance
| Generic name | POTASSIUM IODIDE |
|---|---|
| Sponsor | Roxane |
| Target | Carbonic anhydrase 4 |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 1979 |
Approved indications
- Allergic rhinitis
- Common cold
- Cough
- Nasal congestion
- Nasal discharge
- Thyroid Gland Radiation Protection
Common side effects
Key clinical trials
- Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima Indians
- Comparison of the Clinical Effects of Open, Closed, and Semi-close Hemorrhoidectomy. (NA)
- Traditional vs. Minimally Invasive Decay Treatments in Primary Molars: An 18-month Split-mouth Randomized Study (NA)
- Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter (PHASE3)
- 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma (PHASE2)
- A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study) (NA)
- Chemo Brain Prehab Project (NA)
- MIBG for Refractory Neuroblastoma and Pheochromocytoma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Potassium Iodide CI brief — competitive landscape report
- Potassium Iodide updates RSS · CI watch RSS